EZETIMIBE Side Effects

6753051-6 | Abdominal Pain Upper, Chest Pain, Fatigue, Rash
on Jun 02, 2010 Male patient from UNITED STATES , weighting 215.0 lb, was diagnosed with blood cholesterol increased and was treated with Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, chest pain (What is chest pain?), fatigue, rash (What is rash?). Ezetimibe dosage: 10 Mg 1 - Day.

6731625-6 | Renal Failure Acute, Rhabdomyolysis
Patient was taking Ezetimibe (View Usage). Patient had the following side effects: renal failure acute, rhabdomyolysis on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 35 years of age, weighting 304.2 lb, was diagnosed with hypercholesterolaemia and. Ezetimibe dosage: 10mg Daily Po. During the same period patient was treated with FENOFIBRATE (145mg Daily Po) (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

6656883-8 | Blood Creatine Phosphokinase Increased, Myalgia
Adverse event was reported on Mar 29, 2010 by a Male patient taking Ezetimibe (View Usage) (Dosage: 10mg Once Daily Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , weighting 209.0 lb, After Ezetimibe was administered, patient had the following side effects: blood creatine phosphokinase increased, myalgia.

6594052-0 | Blood Triglycerides Increased, Pancreatitis Acute
on Feb 18, 2010 Male patient from UNITED STATES , 54 years of age, weighting 300.9 lb, was diagnosed with pancreatitis acute and was treated with Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: blood triglycerides increased, pancreatitis acute. Ezetimibe dosage: 5 Mg Every Day Po. Patient was hospitalized.


6516623-X | Actinic Keratosis, Arrhythmia, Arthralgia, Contusion, Corneal Abrasion, Erythrasma, Fall, Fungal Infection, Fungal Skin Infection
on Dec 20, 2009 Male patient from UNITED KINGDOM , 49 years of age, was diagnosed with blood cholesterol increased, erectile dysfunction (What is erectile dysfunction?), osteoporosis prophylaxis and was treated with Ezetimibe (View Usage). Patient had the following side effects: actinic keratosis, arrhythmia (What is arrhythmia?), arthralgia, contusion, corneal abrasion, erythrasma, fall (What is fall?), fungal infection (What is fungal infection?), fungal skin infection. Ezetimibe dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.

6381448-5 | Actinic Keratosis, Arrhythmia, Arthralgia, Corneal Abrasion, Erythrasma, Fall, Fungal Infection, Fungal Skin Infection, Groin Pain
Patient was taking Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: actinic keratosis, arrhythmia (What is arrhythmia?), arthralgia, corneal abrasion, erythrasma, fall (What is fall?), fungal infection (What is fungal infection?), fungal skin infection, groin pain on Sep 22, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 49 years of age, was diagnosed with blood cholesterol increased, erectile dysfunction (What is erectile dysfunction?), osteoporosis prophylaxis and. Ezetimibe dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VIAGRA (View Viagra Review and Viagra Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.

6312288-0 | Amyotrophic Lateral Sclerosis
Adverse event was reported on Aug 03, 2009 by a Female patient taking Ezetimibe (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). During the same period patient was treated with FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VYTORIN (View Vytorin Review and Vytorin Label ).

6305048-8 | Amyotrophic Lateral Sclerosis, Muscular Weakness
on Jul 28, 2009 Female patient from UNITED STATES , 48 years of age, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). Patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), muscular weakness. Ezetimibe dosage: . During the same period patient was treated with FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VYTORIN (View Vytorin Review and Vytorin Label ).

6300706-3 | Amyotrophic Lateral Sclerosis
on Jul 28, 2009 Female patient from UNITED STATES , 48 years of age, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). Ezetimibe dosage: . During the same period patient was treated with FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VYTORIN (View Vytorin Review and Vytorin Label ), UBIDECARENONE (View Ubidecarenone Review and Ubidecarenone Label ).

6257136-2 | Fatigue, Flank Pain, Myalgia, Tachycardia
Patient was taking Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, flank pain, myalgia, tachycardia on Jul 01, 2009 from UNITED STATES Additional patient health information: Female patient , 68 years of age, . Ezetimibe dosage: 10mg Daily Po. During the same period patient was treated with GRENGRAF (View Grengraf Review and Grengraf Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), FLONASE (View Flonase Review and Flonase Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6247569-2 | Phlebitis, Pulmonary Embolism
Adverse event was reported on Jun 10, 2009 by a Female patient taking Ezetimibe (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, thyroidectomy and. Location: FRANCE , 69 years of age, Patient had the following side effects: phlebitis, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DIACEREIN (View Diacerein Review and Diacerein Label ). Patient was hospitalized.

6156824-6 | Cholelithiasis, Pancreatitis Acute
on Apr 13, 2009 Female patient from UNITED STATES , 79 years of age, weighting 174.2 lb, was diagnosed with hypercholesterolaemia and was treated with Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: cholelithiasis, pancreatitis acute. Ezetimibe dosage: 10mg Qd Po. Patient was hospitalized.

6129163-7 | Cholecystitis
on Mar 23, 2009 Male patient from UNITED STATES , 77 years of age, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis. Ezetimibe dosage: 10 Mg Every Day Po. Patient was hospitalized.

6123687-4 | Abdominal Pain
Patient was taking Ezetimibe (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?) on Mar 18, 2009 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with hyperlipidaemia and. Ezetimibe dosage: .

6120989-2 | Angina Pectoris, Arthralgia, Bradycardia, Chest Pain, Dizziness, Dyspnoea, Hypoaesthesia, Musculoskeletal Pain, Myalgia
Adverse event was reported on Mar 12, 2009 by a Male patient taking Ezetimibe (View Usage) (Dosage: 10 Mg Every Day Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 66 years of age, weighting 228.0 lb, After Ezetimibe was administered, patient had the following side effects: angina pectoris, arthralgia, bradycardia, chest pain (What is chest pain?), dizziness (What is dizziness?), dyspnoea, hypoaesthesia, musculoskeletal pain, myalgia. Patient was hospitalized.

6096723-1 | Blood Creatine Phosphokinase Increased
on Feb 25, 2009 Male patient from UNITED STATES , 49 years of age, weighting 299.0 lb, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. Ezetimibe dosage: 5 Mg Every Day Po.

6074442-5 | Anoxic Encephalopathy, Cardio-respiratory Arrest, Cerebrovascular Accident, Cor Pulmonale, Cytolytic Hepatitis, Diabetes Mellitus Inadequate Control, Diabetic Macroangiopathy, Diabetic Microangiopathy, Hypoglycaemia
on Jan 28, 2009 Female patient from SPAIN , 63 years of age, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). Patient had the following side effects: anoxic encephalopathy, cardio-respiratory arrest, cerebrovascular accident, cor pulmonale, cytolytic hepatitis, diabetes mellitus inadequate control, diabetic macroangiopathy, diabetic microangiopathy, hypoglycaemia. Ezetimibe dosage: 10 Mg/q12h. During the same period patient was treated with ATORVASTATIN CALCIUM (80 Mg Daily) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), HYDROXOCOBALAMIN (+) PYRIDOXINE HYDROCHLORIDE (View Hydroxocobalamin (+) Pyridoxine Hydrochloride Review and Hydroxocobalamin (+) Pyridoxine Hydrochloride Label ). Patient was hospitalized.

5965382-8 | Asthenia, Dyspnoea Exertional, Fatigue, Myalgia
Patient was taking Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: asthenia, dyspnoea exertional, fatigue, myalgia on Nov 24, 2008 from ROMANIA Additional patient health information: Female patient , 30 years of age, weighting 132.3 lb, was diagnosed with blood cholesterol increased and. Ezetimibe dosage: 10 Mg Once Daily Po. During the same period patient was treated with EZETROL (View Ezetrol Review and Ezetrol Label ).

5932091-0 | Muscle Spasms, Myalgia
Adverse event was reported on Sep 30, 2008 by a Female patient taking Ezetimibe (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: NETHERLANDS , 52 years of age, Patient experienced the following unwanted or unexpected effects: muscle spasms, myalgia. During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ).

5927900-5 | Arthralgia, Asthenia, Back Pain, Pain In Extremity
on Oct 22, 2008 Male patient from UNITED STATES , weighting 186.0 lb, was diagnosed with hypercholesterolaemia and was treated with Ezetimibe (View Usage). Patient had the following side effects: arthralgia, asthenia, back pain (What is back pain?), pain in extremity. Ezetimibe dosage: 10mg Once Daily Po. During the same period patient was treated with ISRADIPINE (View Isradipine Review and Isradipine Label ), NIACIN (View Niacin Review and Niacin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), DUTASTERIDE (View Dutasteride Review and Dutasteride Label ), FLOMAX (View Flomax Review and Flomax Label ), LEVITRA (View Levitra Review and Levitra Label ).

5912332-6 | Alanine Aminotransferase Increased, Multi-organ Failure
on Oct 02, 2008 Male patient from NORWAY , 69 years of age, was diagnosed with hypercholesterolaemia, hypertension and was treated with Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: alanine aminotransferase increased, multi-organ failure. Ezetimibe dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

5863106-6 | Atrial Fibrillation, Device Related Infection, Diarrhoea, Hip Arthroplasty, Liver Disorder, Migraine, Multi-organ Failure, Muscular Weakness
Patient was taking Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), device related infection, diarrhoea, hip arthroplasty, liver disorder, migraine (What is migraine?), multi-organ failure, muscular weakness on Aug 07, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 69 years of age, weighting 176.4 lb, was diagnosed with infection (What is infection?) and. Ezetimibe dosage: . During the same period patient was treated with ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), FUSIDATE SODIUM (View Fusidate Sodium Review and Fusidate Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), SUMATRIPTAN SUCCINATE (View Sumatriptan Succinate Review and Sumatriptan Succinate Label ). Patient was hospitalized.

5853322-1 | Acute Coronary Syndrome, Device Related Infection, Diarrhoea, Hip Arthroplasty, Liver Disorder, Migraine, Multi-organ Failure, Muscular Weakness
Adverse event was reported on Aug 07, 2008 by a Male patient taking Ezetimibe (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: UNITED KINGDOM , 69 years of age, weighting 176.4 lb, Patient had the following side effects: acute coronary syndrome, device related infection, diarrhoea, hip arthroplasty, liver disorder, migraine (What is migraine?), multi-organ failure, muscular weakness. During the same period patient was treated with ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), FUSIDATE SODIUM (View Fusidate Sodium Review and Fusidate Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), SUMATRIPTAN SUCCINATE (View Sumatriptan Succinate Review and Sumatriptan Succinate Label ). Patient was hospitalized.

5808629-0 | Renal Failure Acute, Rhabdomyolysis
on Jul 09, 2008 Male patient from UNITED STATES , 59 years of age, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: renal failure acute, rhabdomyolysis. Ezetimibe dosage: 10 Mg Every Day Po. During the same period patient was treated with NIACIN (750 Mg Every Day Po) (View Niacin Review and Niacin Label ).

5776040-7 | Abdominal Pain Upper, Dyspepsia, Hepatitis Acute, Vomiting
on Apr 29, 2008 Female patient from UNITED KINGDOM , 50 years of age, was diagnosed with blood cholesterol increased, coronary artery disease (What is coronary artery disease?) and was treated with Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, dyspepsia, hepatitis acute, vomiting. Ezetimibe dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ACETAMINOPHEN AND DIHYDROCODEINE BITARTRATE (View Acetaminophen And Dihydrocodeine Bitartrate Review and Acetaminophen And Dihydrocodeine Bitartrate Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ). Patient was hospitalized and became disabled.

5763988-2 | Rash, Skin Burning Sensation
Patient was taking Ezetimibe (View Usage). Patient had the following side effects: rash (What is rash?), skin burning sensation on Jun 04, 2008 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 195.8 lb, was diagnosed with hyperlipidaemia and. Ezetimibe dosage: 5 Mg Every Day Po.

5762963-1 | Mucosal Haemorrhage, Mucosal Inflammation, Oedema Mucosal
Adverse event was reported on May 28, 2008 by a Male patient taking Ezetimibe (View Usage) (Dosage: Unk) was diagnosed with coronary artery disease (What is coronary artery disease?) and. Location: UNITED STATES , 61 years of age, After Ezetimibe was administered, patient had the following side effects: mucosal haemorrhage, mucosal inflammation, oedema mucosal. During the same period patient was treated with ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (Unk) (View Clopidogrel Review and Clopidogrel Label ).

5742415-5 | Blood Creatine Phosphokinase Increased
on May 14, 2008 Male patient from UNITED STATES , 42 years of age, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. Ezetimibe dosage: .

5711556-0 | Rhabdomyolysis
on Apr 18, 2008 Female patient from UNITED STATES , weighting 158.7 lb, was diagnosed with hypercholesterolaemia and was treated with Ezetimibe (View Usage). Patient had the following side effects: rhabdomyolysis. Ezetimibe dosage: 10 Mg Daily Po. Patient was hospitalized.

5656866-0 | Blood Creatine Phosphokinase Increased, Chest Discomfort, Hepatic Enzyme Increased, Overdose, Seborrhoeic Dermatitis
Patient was taking Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: blood creatine phosphokinase increased, chest discomfort, hepatic enzyme increased, overdose, seborrhoeic dermatitis on Mar 06, 2008 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 202.0 lb, . Ezetimibe dosage: 10mg Every Day Po. Patient was hospitalized.

5591412-1 | Abdominal Pain, Faeces Discoloured, Thrombocytopenia
Adverse event was reported on Jan 11, 2008 by a Male patient taking Ezetimibe (View Usage) (Dosage: 5 Mg Every Day Po) was diagnosed with cerebrovascular accident prophylaxis and. Location: UNITED STATES , 83 years of age, weighting 210.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), faeces discoloured, thrombocytopenia.

5554615-8 | Blood Creatine Phosphokinase Increased
on Dec 10, 2007 Male patient from UNITED STATES , 75 years of age, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). Patient had the following side effects: blood creatine phosphokinase increased. Ezetimibe dosage: 5mg Every Day Po.

5493392-6 | Arthralgia, Cholelithiasis, Chronic Hepatitis, Diarrhoea, Liver Injury, Myalgia
on Oct 22, 2007 Male patient from UNITED STATES , 65 years of age, was treated with Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: arthralgia, cholelithiasis, chronic hepatitis, diarrhoea, liver injury, myalgia. Ezetimibe dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ).

5470229-2 | Acute Coronary Syndrome
Patient was taking Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome on Sep 26, 2007 from LATVIA Additional patient health information: Male patient , 69 years of age, weighting 189.6 lb, was diagnosed with hypercholesterolaemia and. Ezetimibe dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

5462976-3 | Myalgia
Adverse event was reported on Sep 18, 2007 by a Male patient taking Ezetimibe (View Usage) (Dosage: 10mg Every Day Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 85 years of age, Patient had the following side effects: myalgia.

5455362-3 | Arthralgia, Myalgia, Tendonitis
on Sep 13, 2007 Male patient from UNITED STATES , weighting 185.0 lb, was diagnosed with hypercholesterolaemia and was treated with Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: arthralgia, myalgia, tendonitis. Ezetimibe dosage: 10 Mg Daily Po.

5347657-9 | Blood Creatine Phosphokinase Increased, Muscular Weakness
on Jun 04, 2007 Female patient from UNITED STATES , 60 years of age, weighting 145.5 lb, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, muscular weakness. Ezetimibe dosage: 10 Mg Daily Po. During the same period patient was treated with LIPITOR (Range 10-40 Mg Daily Po) (View Lipitor Review and Lipitor Label ), GLUCOPHAGE XR (View Glucophage Xr Review and Glucophage Xr Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5329785-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Patient was taking Ezetimibe (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased on May 17, 2007 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 235.0 lb, was diagnosed with hypercholesterolaemia and. Ezetimibe dosage: 10mg Daily Po.

5323711-2 | Hepatic Enzyme Abnormal
Adverse event was reported on May 10, 2007 by a Female patient taking Ezetimibe (View Usage) (Dosage: ) . Location: UNITED STATES , 25 years of age, After Ezetimibe was administered, patient had the following side effects: hepatic enzyme abnormal.

5308198-8 | Leukocytoclastic Vasculitis
on Apr 23, 2007 Male patient from UNITED STATES , 76 years of age, weighting 276.5 lb, was diagnosed with hyperlipidaemia and was treated with Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis. Ezetimibe dosage: 5 Mg Nightly Po.

5288829-1 | Blood Creatine Phosphokinase Increased, Fall, Muscular Weakness
on Mar 29, 2007 Female patient from CANADA , 73 years of age, was diagnosed with hyperlipidaemia, atrial fibrillation (What is atrial fibrillation?), arteriosclerosis coronary artery and was treated with Ezetimibe (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, fall (What is fall?), muscular weakness. Ezetimibe dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5228564-9 | Myalgia
Patient was taking Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: myalgia on Jan 31, 2007 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 149.9 lb, . Ezetimibe dosage: .

5171169-9 | Myalgia, Paralysis
Adverse event was reported on Dec 08, 2006 by a Female patient taking Ezetimibe (View Usage) (Dosage: 10 Mg, Qday, Po) . Location: UNITED STATES , 60 years of age, weighting 210.1 lb, Patient experienced the following unwanted or unexpected effects: myalgia, paralysis (What is paralysis?).

5134198-7 | Fall, Myopathy, Troponin Increased
on Oct 04, 2006 Male patient from UNITED KINGDOM , 91 years of age, was diagnosed with diabetes mellitus and was treated with Ezetimibe (View Usage). Patient had the following side effects: fall (What is fall?), myopathy, troponin increased. Ezetimibe dosage: 10 Mg, Oral. During the same period patient was treated with SIMVASTATIN (40 Mg, Oral) (View Simvastatin Review and Simvastatin Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GTN S (View Gtn-s Review and Gtn-s Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized and became disabled.

5113507-9 | Myalgia
on Sep 21, 2006 Male patient from UNITED STATES , 70 years of age, weighting 205.9 lb, was treated with Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: myalgia. Ezetimibe dosage: .

5076146-4 | Blood Creatinine Increased, Blood Urea Increased
Patient was taking Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased on Aug 03, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 66 years of age, weighting 176.4 lb, was diagnosed with blood cholesterol increased, angina pectoris, seasonal allergy and. Ezetimibe dosage: . During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), CETIRIZINE HYDROCHLORIDE (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ). Patient was hospitalized.

5070167-3 | Abdominal Pain
Adverse event was reported on Aug 02, 2006 by a Male patient taking Ezetimibe (View Usage) (Dosage: Po Q Day) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 69 years of age, weighting 189.8 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?). During the same period patient was treated with SIMVASTATIN (Po Q Day) (View Simvastatin Review and Simvastatin Label ).

5066520-4 | Hypokalaemia, Myalgia, Rhabdomyolysis
on Jul 31, 2006 Male patient from UNITED STATES , weighting 120.0 lb, was diagnosed with hypercholesterolaemia and was treated with Ezetimibe (View Usage). After Ezetimibe was administered, patient had the following side effects: hypokalaemia, myalgia, rhabdomyolysis. Ezetimibe dosage: 10 Mg Daily Po. During the same period patient was treated with SIMVASTATIN (20 Mg Daily Po) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

4980365-2 | Myalgia
on Apr 21, 2006 Male patient from UNITED STATES , 73 years of age, weighting 187.4 lb, was diagnosed with blood cholesterol and was treated with Ezetimibe (View Usage). Patient experienced the following unwanted or unexpected effects: myalgia. Ezetimibe dosage: 10mg Qd Po. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ).

4966820-X | Monoparesis
Patient was taking Ezetimibe (View Usage). Patient had the following side effects: monoparesis on Feb 22, 2006 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with hypercholesterolaemia, anxiety (What is anxiety?) and. Ezetimibe dosage: . During the same period patient was treated with PRAZEPAM (View Prazepam Review and Prazepam Label ). Patient was hospitalized.